Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

BMS partners BioNTech in US$ 11 bn cancer drug deal; Sanofi to acquire Blueprint Medicines for US$ 9.5 bn

The pharmaceutical sector saw several significant deals with major players expanding their portfolios. Bristol Myers Squibb (BM...

Impressions : 359

Lilly expands pain pipeline via US$ 1 bn SiteOne buyout; US cancels funding for Moderna's bird flu vaccine

In news this week, Eli Lilly has placed a billion-dollar bet on non-opioid pain management by acquiring SiteOne Therapeutics fo...

Impressions : 557

Pfizer inks US$ 6 bn oncology deal with China's 3SBio; BioNTech to invest US$ 1.3 bn in UK for new R&D, AI centers

In news this week, Pfizer announced a US$ 6 billion licensing agreement with China’s 3SBio, securing global rights to a p...

Impressions : 581

Trump signs 'most favored nation' executive order to slash drug costs; Sanofi, Takeda pledge mega investments in US

The US President Donald Trump’s dramatic intervention in pharmaceutical pricing took centerstage as the White House unvei...

Impressions : 696

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

BMS partners BioNTech in US$ 11 bn cancer drug deal; Sanofi to acquire Blueprint Medicines for US$ 9.5 bn

Lilly expands pain pipeline via US$ 1 bn SiteOne buyout; US cancels funding for Moderna's bird flu vaccine

Pfizer inks US$ 6 bn oncology deal with China's 3SBio; BioNTech to invest US$ 1.3 bn in UK for new R&D, AI centers

Trump signs 'most favored nation' executive order to slash drug costs; Sanofi, Takeda pledge mega investments in US

Avit's Generics Sitagliptin Receives Approval in US

Dr Reddy's Generics Sitagliptin Receives Approval in US

MSN's Generics Sacubitril Receives Tentative Approval in US

Boehringer 's Biologics Spevigo Receives Suppl Approval in US

BMS's Biologics Yervoy Receives Suppl Approval in US

BMS's Biologics Opdivo Receives Suppl Approval in US

BMS's Biologics Opdivo Qvantig Receives Suppl Approval in US

GSK's Biologics Nucala Receives Suppl Approval in US

Merck's Biologics Keytruda Receives Suppl Approval in US

Celltrion's Biologics Herzuma Receives Suppl Approval in US

Enforcement Report - Week of June 4, 2025

Zhejiang Easyclean Daily Chemical Recieves Warning Letter

Evi Labs Recieves Warning Letter

Yiling Pharmaceutical Recieves Warning Letter

CTK OTC Laboratories Recieves Warning Letter

Rechon Life Science Recieves Warning Letter

Enforcement Report - Week of May 28, 2025

Everlaan Organics is on FDA Import Alert List

Umary Issues a Nationwide Recall of Unavy Acidio Hialuronico

Enforcement Report - Week of May 21, 2025

Nemluvio Long-Term Data Show Gains in Atopic Dermatitis

Roche's Evrysdi tablet approved in EU

Seyltx Gains Option to Boost Cough Pipeline with 8 NeurOp Drugs

RegenXBio Links DMD Gene Therapy to Improved Outcomes

Cullinan's $700 M Pact for BCMA Bispecific to Pair with Other TCE

Corcept Unveils Promising Survival Data from phase 2 ALS fail

Kennedy Looks to Fast-Tracking Approvals for Rare Disease Drugs

Carbogen Boosts ADC Production ability with $31M in upgrades

Alvotech & Dr. Reddy's Collab to co-develop Keytruda

Hutchmed, Innovent File NDA in China for Renal Cell Carcinoma

Harmony Biosciences Strengthens Patent Position with Settlement

NRx Pharmaceuticals files ANDA for Preservative-Free IV Ketamine

Polpharma Group Backs EU Action to Protect Medicine Access

Gland Pharma receives FDA approval for Angiotensin II Acetate Inj

NPPA Sets Prices for 41 Drug Combos, Including Empagliflozin

AVEO Oncology, LG Chem Present Three Posters at ASCO 2025 Meeting

Avenacy Launches Leuprolide Acetate Injection in U.S. Market

Biocon Gets Approval for Diabetes Drug Liraglutide in India

Zydus gets USFDA nod for Generic IBS-D treatment drug

Repurposing Generic Drugs: New Regulatory Pathway Envisioned

Nemluvio Long-Term Data Show Gains in Atopic Dermatitis

Seyltx Gains Option to Boost Cough Pipeline with 8 NeurOp Drugs

RegenXBio Links DMD Gene Therapy to Improved Outcomes

Cullinan's $700 M Pact for BCMA Bispecific to Pair with Other TCE

Carbogen Boosts ADC Production ability with $31M in upgrades

Alvotech & Dr. Reddy's Collab to co-develop Keytruda

Hutchmed, Innovent File NDA in China for Renal Cell Carcinoma

EMA Floats 'change in Paradigm' for Pregnant Patients in Trials

Biocytogen Secures Japan Patent for RenMab Platform

Sonoma Biotherapeutics to Present Poster at 2025 EULAR Congress

Santosh Mahil appointed CEO of Sekhmet Pharmaventures

API prices drop, easing pressure on India's pharma industry

Frédéric Robert Appointed EUROAPI's Chief Commercial Officer

Lonza Launches Design2Optimize for Small Molecule API Development

Lilly weighs Houston as option for new $5.9B API facility

Skyepharma Expands Oncology Operational Facility in France

Zydus receives EIR for the Ambernath API manufacturing facility

Benuvia Operations Signs Supply Deal for Dronabinol API

IGC Pharma Presents Genetic Toxicology Data at 2025 Meeting

Sigachi Industries Gets Cep for Metformin Hydrochloride from Edqm

Argentina Recalls Fentanyl Lots After Dozens Die

US FDA's Surprise Foreign Inspections Plan Impact on India

Piramal Pharma completes USFDA inspection of Aurora facility

Pharmala Biotech Warns Against Fake Products Claiming to Be Their

Gene editing leaders call for 10-year ban on heritable edits

FDA Issues Warning Letters to Drugmaker, Diagnostics Firm for GMP

US Appeals Court Rejects Challenge to Federal Marijuana Ban

Dr Reddy's gets 2 observations from USFDA for Telangana API plant

FDA Warns About GMP Violations, False Drug Advertising

Alpha Genesis Passes USDA Inspection, Advances Health Mission

Sarah Harkcom Wins European Legal Innovation & Technology Award

Foldax Secures Approval for TRIA Mitral Heart Valve in India

Court Validates Kalderos Push for 340B Drug Pricing Reform